Thanh Huong PHUNG

Prof. Thanh Huong PHUNG

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in Cancers
Verified
Journal Article
Open access
PDF file
TPThanh Huong PHUNG
Thanh Huong PHUNG
LNLap Thi Nguyen
Lap Thi Nguyen
XNXuan-Bac Nguyen
Xuan-Bac Nguyen
SLSang Kook Lee
Sang Kook Lee
DBDuc-Hiep Bach
Duc-Hiep Bach
Besides the critical functions in hemostasis, thrombosis and the wounding process, platelets have been increasingly identified as active players in various processes in tumorigenesis, including angiogenesis and metastasis. Once activated, platelets can release bioactive contents such as lipids, microRNAs, and growth factors into the bloodstream, subsequently enhancing the platelet–cancer interaction and stimulating cancer metastasis and angiogenesis. The mechanisms of treatment failure of chemotherapeutic drugs have been investigated to be associated with platelets. Therefore, understanding how platelets contribute to the tumor microenvironment may potentially identify strategies to suppress cancer angiogenesis, metastasis, and drug resistance. Herein, we present a review of recent investigations on the role of platelets in the tumor-microenvironment including angiogenesis, and metastasis, as well as targeting platelets for cancer treatment, especially in drug resistance.

15 March 2020 in Cancers
Verified
Journal Article
Open access
PDF file
TPThanh Huong PHUNG
Thanh Huong PHUNG
SGSanjeev Gurshaney
Sanjeev Gurshaney
BNBINH NGUYEN
BINH NGUYEN
Pham Gia AnhPham Gia Anh
Pham Gia Anh
HNHuy Hoang Nguyen
Huy Hoang Nguyen
HLHUNG LUU
HUNG LUU
With over 1 million incidence cases and more than 780,000 deaths in 2018, gastric cancer (GC) was ranked as the 5th most common cancer and the 3rd leading cause of cancer deaths worldwide. Though several biomarkers, including carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), and cancer antigen 72-4 (CA72-4), have been identified, their diagnostic accuracies were modest. Circulating tumor cells (CTCs), cells derived from tumors and present in body fluids, have recently emerged as promising biomarkers, diagnostically and prognostically, of cancers, including GC. In this review, we present the landscape of CTCs from migration, to the presence in circulation, biologic properties, and morphologic heterogeneities. We evaluated clinical implications of CTCs in GC patients, including diagnosis, prognosis, and therapeutic management, as well as their application in immunotherapy. On the one hand, major challenges in using CTCs in GC were analyzed, from the differences of cut-off values of CTC positivity, to techniques used for sampling, storage conditions, and CTC molecular markers, as well as the unavailability of relevant enrichment and detection techniques. On the other hand, we discussed future perspectives of using CTCs in GC management and research, including the use of circulating tumor microembolies; of CTC checkpoint blockade in immunotherapy; and of organoid models. Despite the fact that there are remaining challenges in techniques, CTCs have potential as novel biomarkers and/or a non-invasive method for diagnostics, prognostics, and treatment monitoring of GC, particularly in the era of precision medicine.

15 February 2022 in Analytical Methods
Verified
Journal Article
Closed access
PDF file
NLNhan Trong Le
Nhan Trong Le
NHNguyen Thuy Hoang
Nguyen Thuy Hoang
VVVan Tuong Thi Van
Van Tuong Thi Van
TNTrieu Phat Dac Nguyen
Trieu Phat Dac Nguyen
NCNgoc Huyen Thi Chau
Ngoc Huyen Thi Chau
Hien Minh NguyenHien Minh Nguyen
Hien Minh Nguyen
Using waste materials to extract biologically active ingredients with green solvents is a new trend for sustainable development. Herein, different types of deep eutectic solvents (DESs) and surfactant solvents (SSs) were used to extract curcumin from turmeric residues (TRs), among which choline chloride–propylene glycol (ChCl–Pro) showed the highest yield. The optimized extraction conditions included a ChCl : Pro ratio of 1 : 2, water content in the DESs of 20%, solid : liquid ratio of 1 : 40 maintained for 60 min at 50 °C, and a TR particle size of 0.18 mm. The extraction yield was 54.2 mg g−1, which was 1.31 times higher than when methanol was used as a solvent. Distilled water was used to recover curcumin from the DES extract with a recovery yield of 99.7%. Furthermore, the antioxidant and acetylcholinesterase (AChE) inhibitory activities of the recovered curcumin were evaluated, with IC50 values of 25.58 ± 0.51 and 19.12 ± 0.83 μg mL−1, respectively. This study highlights the promising potential of using green solvents to extract bioactive compounds from waste materials.

1 January 2024 in Cancer Control
Verified
Journal Article
Open access
CNCuc Thi Thu Nguyen
Cuc Thi Thu Nguyen
TVTran Nguyen Khanh Van
Tran Nguyen Khanh Van
TPThanh Huong PHUNG
Thanh Huong PHUNG
Objectives: The associations between the neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with the responses of non-small cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors (ICI) and the NLR/PLR predictive potential were evaluated via meta-analysis. Methods: A systematic review was conducted using the PubMed, Embase, and The Cochrane Library databases until October 2021. The relationship between NLR/PLR and overall survival (OS) and progression-free survival (PFS) was evaluated using pooled hazard ratios (HR). The relationship between NLR/PLR and overall response rate (ORR) and disease control rate (DCR) was assessed via pooled odds ratios (OR). Heterogeneity between studies, publication bias, subgroup and sensitivity analyses, trim and fill meta-analysis, and the contour-enhanced funnel plot were performed using the R software. Results: A total of 44 (out of 875) studies met the eligibility criteria, providing a sample size of 4597 patients. Patients with a high NLR were statistically significantly associated with worse outcomes, including OS (pooled HR = 2.44; P < 0.001), PFS (pooled HR = 2.06; P < 0.001), DCR (pooled OR = 0.71; P < 0.001), and ORR (pooled OR = 0.33; P < 0.001). Similarly, a high PLR was associated with poorer outcomes in response to ICI drugs, including OS (pooled HR = 2.13; P < 0.001) and PFS (pooled HR = 1.61; P < 0.001). Conclusion: High NLR and PLR were associated with a statistically significant reduction in the efficacy of ICI drugs in NSCLC patients. Thereby, it is possible to use NLR and PLR as potential and available biomarkers in the clinical practice to predict the outcome of ICI treatment in NSCLC patients.

25 August 2019 in Journal of Medical Biochemistry
Verified
Journal Article
Open access
PDF file
DNDuong Thi Thuy Ngan
Duong Thi Thuy Ngan
NBNguyen Gia Binh
Nguyen Gia Binh
LLLe Thi Huong Lan
Le Thi Huong Lan
CNCuc Thi Thu Nguyen
Cuc Thi Thu Nguyen
TPThanh Huong PHUNG
Thanh Huong PHUNG
Summary: Background: Albuminuria is the standard biomarker for the diagnosis of diabetic nephropathy (DN). However, some patients with persistent microalbuminuria still progress to chronic kidney disease, raising the question of finding a better biomarker. This study aimed to evaluate the correlation of urinary liver-type fatty acid-binding protein (L-FABP) levels with renal function and to compare the role of urinary albumin-to-creatinine ratio (ACR) with urinary L-FABP in early detection of DN in type 2 diabetic patients. Methods: The cross-sectional study was done on 106 type 2 diabetic patients and 30 non-diabetic people. L-FABP was measured with the Latex enhanced immunoturbidimetric technique. Results: There was a strong and negative correlation between the urine L-FABP levels and eGFR (r = -0.606, p<0.001). The urinary L-FABP levels were significantly higher (p<0.001) in the normoalbuminuria diabetic group than the non-diabetic control group. The ROC-curve analyses in the diabetic patients and the normoalbuminuria diabetic patients showed that the AUCL-FABP was remarkably higher (p<0.001) than the AUCACR. An optimal cutoff value of 5 mg L-FABP/g Cr (with the sensitivity of 98.1% and specificity of 90%) and of 4.3 mg L-FABP/g Cr (with the sensitivity of 100% and specificity of 86.67%) was set to detect DN in the diabetic patients and the normoalbuminuria diabetic patients, respectively. Conclusions: The change in urinary L-FABP levels happened earlier than in urinary albumin during renal function impairment. Urinary L-FABP can be used as a better indicator than ACR for early detection of DN in type 2 diabetes.

31 October 2017 in Czech Journal of Food Sciences
Verified
Journal Article
Open access
DNDong Nguyen
Dong Nguyen
ANAlena Nováková
Alena Nováková
KSKlára Spurná
Klára Spurná
JHJiří Hričko
Jiří Hričko
TPThanh Huong PHUNG
Thanh Huong PHUNG
Tomas RumlTomas Ruml
Tomas Ruml
» Articles | Agricultural Journals